The drug industry, with encouragement from the Food and Drug Administration, is advancing efforts to modernize clinical trials, streamlining the process of figuring out whether a treatment actually works.
STAT’s national biotech reporter Damian Garde delved into new approaches, examined case studies, and fielded questions about the future of clinical trials.
About the Author Reprints
